The partnership between Sensyne Health and Microsoft will entail the aim of improving, augmenting, and reducing the cost of patient care.
Expected to deliver latest generation healthcare ‘cloud-first’ systems and predictive machine learning algorithms, while reducing demand on global health systems and increasing scalability of care, the agreement includes the following aspects:
- Increased ability to create globally deployable and configurable healthtech at scale;
- Early access for Sensyne to Microsoft tools, which will bring enhanced cyber security and usability;
- Broadening of global sales channels through promotion of Sensyne products across Microsoft marketing channels;
- The co-selling of remote monitoring system SEND, and prescribed digital therapeutic GDm-Health.
Sensyne’s AI healthcare expertise will be combined with Micosoft’s latest healthcare capabilities. These include clinical workflow and patient engagement tool Health Cloud, digital waiting room and remote consultation service Virtual Consult, and natural language interaction system Health Bot.
Driving healthcare transformation one simple step at a time
“This strategic partnership with Microsoft will further enhance Sensyne’s ability to advance and scale the benefits that advanced clinical AI can bring to improve patient outcomes and accelerate the development of new medicines through its research partnerships with NHS Trusts,” said Lord Paul Drayson, CEO of Sensyne Health.
Laura Robinson, health and life sciences lead at Microsoft Healthcare, commented: “Microsoft is focused on utilising the capabilities of AI and Machine Learning to enhance solutions across the healthcare sector.
“Sensyne Health shares our ambition to streamline and optimise operations in the sector and ultimately deliver better patient care.”
Sensyne, alongside Microsoft, recently launched its new SENSE clinical algorithm engine in the UK, which enables real time decision support.
